All products Antibodies Rabbit anti-CRKL Antibody - middle region

Rabbit anti-CRKL Antibody - middle region

Catalog Number:OM105190

  • Titration: 1.0 ug/ml
    Positive Control: K562 Whole Cell

Product Profile

Product Name Rabbit anti-CRKL Antibody - middle region
Antibody Type Primary Antibodies
Immunogen
The immunogen for Anti-CRKL antibody is: synthetic peptide directed towards the middle region of Human CRKL

Key Feature

Clonality Polyclonal
Isotype IgG
Host Species Rabbit
Tested Applications

WB

WB:1:500~1:2000
Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity

Human

Concentration 1 mg/ml
Purification Affinity purified

Target Information

Gene Symbol CRKL
Gene Synonyms
-
Gene Summary
CRKL has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase and plays a role in fibroblast transformation by BCR-ABL. In addition, CRKL has oncogenic potential.
Molecular Weight(MW) 34kDa
Sequence 303 amino acids

Database Links

Entrez Gene 1399
SwissProt ID P46109
Protein Accession NP_005198

Application

  • Western blot

    Titration: 1.0 ug/ml
    Positive Control: K562 Whole Cell

Application Notes
WB:1:500~1:2000
Notes:Optimal dilutions/concentrations should be determined by the researcher.

Additional Information

Form Liquid
Storage Instructions Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles
Storage Buffer phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.

  • Catalog Number: OM105190
  • Price: $336.00
  • Discount Price
  • Size:
  • Store: In stock
  • Lead time: 2~3 Week
  • Quantity:
    - +
  • Shipping to (Please select)
Search the catalog number from any major antibody supplier/brand in the search bar above. The search engine will return OmnimAbs products for these targets.

2013 © Omnimabs , All Rights Reserved.